Literature DB >> 29066797

Destination of aminoglycoside antibiotics in the 'post-antibiotic era'.

Yoshiaki Takahashi1, Masayuki Igarashi1.   

Abstract

Aminoglycoside antibiotics (AGAs) were developed at the dawn of the antibiotics era and have significantly aided in the treatment of infectious diseases. Aminoglycosides have become one of the four major types of antibiotics in use today and, fortunately, still have an important role in the clinical treatment of severe bacterial infections. In this review, the current usage, modes of action and side effects of AGAs, along with the most common bacterial resistance mechanisms, are outlined. Finally, the recent development situation and possibility of new AGAs in the 'post-antibiotic era' are considered.The Journal of Antibiotics advance online publication, 25 October 2017; doi:10.1038/ja.2017.117.

Entities:  

Year:  2017        PMID: 29066797     DOI: 10.1038/ja.2017.117

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  170 in total

1.  Apramycin, a unique aminocyclitol antibiotic.

Authors:  S O'Connor; L K Lam; N D Jones; M O Chaney
Journal:  J Org Chem       Date:  1976-06-11       Impact factor: 4.354

2.  Isolation and structure of kanamycin inactivated by a cell free system of kanamycin-resistant E. coli.

Authors:  H Umezawa; M Okanishi; R Utahara; K Maeda; S Kondo
Journal:  J Antibiot (Tokyo)       Date:  1967-07       Impact factor: 2.649

3.  Mechanisms of Resistance to Aminoglycoside Antibiotics: Overview and Perspectives.

Authors:  Sylvie Garneau-Tsodikova; Kristin J Labby
Journal:  Medchemcomm       Date:  2015-09-21       Impact factor: 3.597

Review 4.  New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view.

Authors:  Jose M Lopez-Novoa; Yaremi Quiros; Laura Vicente; Ana I Morales; Francisco J Lopez-Hernandez
Journal:  Kidney Int       Date:  2010-09-22       Impact factor: 10.612

Review 5.  Efficacy and safety of aerosolized tobramycin in cystic fibrosis.

Authors:  V B Pai; M C Nahata
Journal:  Pediatr Pulmonol       Date:  2001-10

6.  Coproduction of novel 16S rRNA methylase RmtD and metallo-beta-lactamase SPM-1 in a panresistant Pseudomonas aeruginosa isolate from Brazil.

Authors:  Yohei Doi; Doroti de Oliveira Garcia; Jennifer Adams; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2006-12-11       Impact factor: 5.191

7.  Aminoglycoside activity observed on single pre-translocation ribosome complexes.

Authors:  Michael B Feldman; Daniel S Terry; Roger B Altman; Scott C Blanchard
Journal:  Nat Chem Biol       Date:  2009-11-29       Impact factor: 15.040

8.  A common mechanism of cellular death induced by bactericidal antibiotics.

Authors:  Michael A Kohanski; Daniel J Dwyer; Boris Hayete; Carolyn A Lawrence; James J Collins
Journal:  Cell       Date:  2007-09-07       Impact factor: 41.582

Review 9.  Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.

Authors:  Susan M Cheer; John Waugh; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Chemically related 4,5-linked aminoglycoside antibiotics drive subunit rotation in opposite directions.

Authors:  Michael R Wasserman; Arto Pulk; Zhou Zhou; Roger B Altman; John C Zinder; Keith D Green; Sylvie Garneau-Tsodikova; Jamie H Doudna Cate; Scott C Blanchard
Journal:  Nat Commun       Date:  2015-07-30       Impact factor: 14.919

View more
  16 in total

1.  Design, Multigram Synthesis, and in Vitro and in Vivo Evaluation of Propylamycin: A Semisynthetic 4,5-Deoxystreptamine Class Aminoglycoside for the Treatment of Drug-Resistant Enterobacteriaceae and Other Gram-Negative Pathogens.

Authors:  Takahiko Matsushita; Girish C Sati; Nuwan Kondasinghe; Michael G Pirrone; Takayuki Kato; Prabuddha Waduge; Harshitha Santhosh Kumar; Adrian Cortes Sanchon; Malgorzata Dobosz-Bartoszek; Dimitri Shcherbakov; Mario Juhas; Sven N Hobbie; Thomas Schrepfer; Christine S Chow; Yury S Polikanov; Jochen Schacht; Andrea Vasella; Erik C Böttger; David Crich
Journal:  J Am Chem Soc       Date:  2019-03-13       Impact factor: 15.419

2.  Exploiting evolutionary trade-offs for posttreatment management of drug-resistant populations.

Authors:  Sergey V Melnikov; David L Stevens; Xian Fu; Hui Si Kwok; Jin-Tao Zhang; Yue Shen; Jeffery Sabina; Kevin Lee; Harry Lee; Dieter Söll
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-13       Impact factor: 11.205

3.  The three-dimensional structure of NeoB: An aminotransferase involved in the biosynthesis of neomycin.

Authors:  Garrett T Dow; James B Thoden; Hazel M Holden
Journal:  Protein Sci       Date:  2018-04-02       Impact factor: 6.725

Review 4.  Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria.

Authors:  Hiroshi Ogawara
Journal:  Molecules       Date:  2019-09-21       Impact factor: 4.411

5.  Influence of ring size in conformationally restricted ring I analogs of paromomycin on antiribosomal and antibacterial activity.

Authors:  Michael G Pirrone; Sven N Hobbie; Andrea Vasella; Erik C Böttger; David Crich
Journal:  RSC Med Chem       Date:  2021-08-05

6.  Synthesis of a Pseudodisaccharide Suitable for Synthesis of Ring I Modified 4,5-2-Deoxystreptamine Type Aminoglycoside Antibiotics.

Authors:  Amr Sonousi; Andrea Vasella; David Crich
Journal:  J Org Chem       Date:  2020-05-08       Impact factor: 4.354

7.  Functionally critical residues in the aminoglycoside resistance-associated methyltransferase RmtC play distinct roles in 30S substrate recognition.

Authors:  Meisam Nosrati; Debayan Dey; Atousa Mehrani; Sarah E Strassler; Natalia Zelinskaya; Eric D Hoffer; Scott M Stagg; Christine M Dunham; Graeme L Conn
Journal:  J Biol Chem       Date:  2019-10-08       Impact factor: 5.486

8.  Paromomycin production from Streptomyces rimosus NRRL 2455: statistical optimization and new synergistic antibiotic combinations against multidrug resistant pathogens.

Authors:  Asmaa A Ibrahim; Ghadir S El-Housseiny; Khaled M Aboshanab; Mahmoud A Yassien; Nadia A Hassouna
Journal:  BMC Microbiol       Date:  2019-01-18       Impact factor: 3.605

9.  Synthesis and Antibacterial Activity of Propylamycin Derivatives Functionalized at the 5''- and Other Positions with a View to Overcoming Resistance Due to Aminoglycoside Modifying Enzymes.

Authors:  Dimitrijs Lubriks; Rimants Zogota; Vikram A Sarpe; Takahiko Matsushita; Girish C Sati; Klara Haldimann; Marina Gysin; Erik C Böttger; Andrea Vasella; Edgars Suna; Sven N Hobbie; David Crich
Journal:  ACS Infect Dis       Date:  2021-06-11       Impact factor: 5.578

10.  Synthesis of Ring II/III Fragment of Kanamycin: A New Minimum Structural Motif for Aminoglycoside Recognition.

Authors:  Sandra G Zárate; Agatha Bastida; Andrés G Santana; Julia Revuelta
Journal:  Antibiotics (Basel)       Date:  2019-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.